Literature DB >> 31731534

Erratum: Hong, E., et al. Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells. Molecules 2019, 24, 1094.

Enping Hong1, Justin R Halman2, Ankit Shah1, Edward Cedrone1, Nguyen Truong2, Kirill A Afonin2, Marina A Dobrovolskaia1.   

Abstract

The Molecules Editorial Office wishes to make the following erratum to this paper [...].

Entities:  

Year:  2019        PMID: 31731534      PMCID: PMC6864657          DOI: 10.3390/molecules24213852

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


The Molecules Editorial Office wishes to make the following erratum to this paper [1]. The reference citation in the legend of Figure 2 was incorrect in the published paper in Molecules [1]. Therefore, it is corrected by the Editorial Office from: (Figure 2. The response of dendritic cell (DC) subsets to delivered NANPs. NANPs were delivered to cells from major DC subsets purified by negative selection, and resulting supernatants were assayed for IFN production. The purified DC subsets tested were (A) plasmacytoid DCs, (B) monocytes, and (C) myeloid DCs. Additionally, isolated monocytes were differentiated into (D) monocyte-derived DCs, which were also tested for IFN induction. Some data from individual donors presented in this figure were adapted from our earlier study (1) with permission. ODN = ODN2216, an oligonucleotide, known to induce interferon response and used in our study as a positive control.) To: (Figure 2. The response of dendritic cell (DC) subsets to delivered NANPs. NANPs were delivered to cells from major DC subsets purified by negative selection, and resulting supernatants were assayed for IFN production. The purified DC subsets tested were (A) plasmacytoid DCs, (B) monocytes, and (C) myeloid DCs. Additionally, isolated monocytes were differentiated into (D) monocyte-derived DCs, which were also tested for IFN induction. Some data from individual donors presented in this figure were adapted from our earlier study [33] with permission. ODN = ODN2216, an oligonucleotide, known to induce interferon response and used in our study as a positive control.) We apologize for any inconvenience caused to the readers by this mistake. The manuscript will be updated and the original will remain online on the article webpage.
  1 in total

1.  Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells.

Authors:  Enping Hong; Justin R Halman; Ankit Shah; Edward Cedrone; Nguyen Truong; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2019-03-20       Impact factor: 4.411

  1 in total
  8 in total

Review 1.  Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs).

Authors:  Morgan Chandler; Morgan Brittany Johnson; Martin Panigaj; Kirill A Afonin
Journal:  Curr Opin Biotechnol       Date:  2019-11-25       Impact factor: 9.740

2.  Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology.

Authors:  Kirill A Afonin; Marina A Dobrovolskaia; George Church; Mark Bathe
Journal:  ACS Nano       Date:  2020-07-24       Impact factor: 15.881

3.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

4.  The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification.

Authors:  Morgan Brittany Johnson; Justin R Halman; Daniel K Miller; Joseph S Cooper; Emil F Khisamutdinov; Ian Marriott; Kirill A Afonin
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

5.  Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.

Authors:  Ridhima Juneja; Hemapriyadarshini Vadarevu; Justin Halman; Mubin Tarannum; Lauren Rackley; Jacob Dobbs; Jose Marquez; Morgan Chandler; Kirill Afonin; Juan L Vivero-Escoto
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-18       Impact factor: 9.229

Review 6.  Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.

Authors:  Martin Panigaj; M Brittany Johnson; Weina Ke; Jessica McMillan; Ekaterina A Goncharova; Morgan Chandler; Kirill A Afonin
Journal:  ACS Nano       Date:  2019-11-05       Impact factor: 15.881

Review 7.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

Review 8.  Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).

Authors:  Weina Ke; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-06-16       Impact factor: 17.873

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.